menu
    • menu

    Company profile for Bioporto

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BioPorto is an in vitro diagnostics company that provides tests and antibodies to clinicians and researchers around the world. We use our antibody and assay expertise to transform novel research tools into clinically actionable biomarkers that can make a difference in patients’ lives. BioPorto is headquartered in Hellerup, Denmark, with US headquarters in Needham, Massachusetts, and is listed on the NASDAQ Copenhagen stock e...
    BioPorto is an in vitro diagnostics company that provides tests and antibodies to clinicians and researchers around the world. We use our antibody and assay expertise to transform novel research tools into clinically actionable biomarkers that can make a difference in patients’ lives. BioPorto is headquartered in Hellerup, Denmark, with US headquarters in Needham, Massachusetts, and is listed on the NASDAQ Copenhagen stock exchange.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BioportoDenmark Flag
    Country
    Country
    Denmark
    Address
    Address
    Tuborg Havnevej 15, st. 2900 Hellerup
    Telephone
    Telephone
    +45 45 29 00 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://bioporto.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/bioporto-diagnostics-a-s/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/BioPortoDx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Annual General Meeting Resolutions
    Annual General Meeting Resolutions

    24 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/24/3280911/0/en/resolutions-of-the-annual-general-meeting.html

    GLOBENEWSWIRE
    24 Apr 2026
    Share Share
    Grant of Warrants Approved
    Grant of Warrants Approved

    14 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/14/3273816/0/en/Grant-of-Warrants.html

    GLOBENEWSWIRE
    14 Apr 2026
    Share Share
    Major Shareholder Announcement
    Major Shareholder Announcement

    13 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/13/3272255/0/en/Major-Shareholder-Announcement.html

    GLOBENEWSWIRE
    13 Apr 2026
    Share Share
    KDIGO Releases 2026 Draft Guideline on AKI and AKD Disease
    KDIGO Releases 2026 Draft Guideline on AKI and AKD Disease

    31 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/31/3265271/0/en/KDIGO-publishes-2026-Clinical-Practice-Guideline-Draft-for-Acute-Kidney-Injury-and-Acute-Kidney-Disease.html

    GLOBENEWSWIRE
    31 Mar 2026
    Share Share
    BioPorto Files FDA Pre-Sub for Adult Urine NGAL Program
    BioPorto Files FDA Pre-Sub for Adult Urine NGAL Program

    31 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/31/3265802/0/en/BioPorto-Advances-U-S-Adult-Urine-NGAL-Program-with-FDA-Pre-Submission-Request-After-Positive-EPACRA-AKI-Cut-Off-Analysis.html

    GLOBENEWSWIRE
    31 Mar 2026
    Share Share
    Notice convening the Annual General Meeting in BioPorto A/S
    Notice convening the Annual General Meeting in BioPorto A/S

    26 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/26/3262779/0/en/Notice-convening-the-Annual-General-Meeting-in-BioPorto-A-S.html

    GLOBENEWSWIRE
    26 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search